DGAP-PVR: STADA Arzneimittel AG: Release according to

STADA Arzneimittel AG 30.09.2014 12:35 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Today STADA Arzneimittel AG, Bad Vilbel, Germany, has received the following letter from BlackRock Investment Management (UK) Limited: Following a review, conducted in close collaboration with the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin), of the way BlackRock has interpreted its voting rights disclosure obligations under German law, BlackRock entities are filing today a statement representing their holdings as at the settlement date of 25 September 2014 in STADA Arzneimittel Aktiengesellschaft. The statement does not reflect a change in BlackRock's current holdings of voting rights. The statement simply updates information currently in the market regarding BlackRock's holdings in STADA Arzneimittel Aktiengesellschaft. Further, the statement does not signify any change in investment strategies pursued. Also, BlackRock issues a press release detailing the BlackRock group entities and their respective voting rights applicable to STADA Arzneimittel Aktiengesellschaft and other relevant German issuers on http://www.blackrock.com/corporate/en-gb/news...s-releases and on Bloomberg. VOTING RIGHTS DISCLOSURE 1. BlackRock, lnc. Section 21, 22 BlackRock, lnc., New York, NY, U.S.A., hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of STADA Arzneimittel Aktiengesellschaft (ISIN DE0007251803) on 25 September 2014 amounts to 2.37% (this corresponds to 1,435,866 out of a total of 60,533,360 voting rights (the 'Total Voting Rights')). 1.43% of the Total Voting Rights (this corresponds to 865,475 voting rights) are to be attributed to BlackRock, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG. 0.75% of the Total Voting Rights (this corresponds to 455,881 voting rights) are to be attributed to BlackRock, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.05% of the Total Voting Rights (this corresponds to 30,890 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.14% of the Total Voting Rights (this corresponds to 83,620 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 2 in connection with sentence 2 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 2. BlackRock Holdco 2, lnc. Section 21, 22 BlackRock Holdco 2, lnc., Wilmington, DE, U.S.A., hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of STADA Arzneimittel Aktiengesellschaft (lSIN DE0007251803) on 25 September 2014 amounts to 2.37% (this corresponds to 1,435,866 out of a total of 60,533,360 voting rights (the 'Total Voting Rights')). 1.43% of the Total Voting Rights (this corresponds to 865,475 voting rights) are to be attributed to BlackRock Holdco 2, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG. 0.75% of the Total Voting Rights (this corresponds to 455,881 voting rights) are to be attributed to BlackRock Holdco 2, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.05% of the Total Voting Rights (this corresponds to 30,890 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.14% of the Total Voting Rights (this corresponds to 83,620 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 2 In connection with sentence 2 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 3. BlackRock Financial Management, lnc. Section 21, 22 BlackRock Financial Management, lnc., New York, NY, U.S.A., hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of STADA Arzneimittel Aktiengesellschaft (ISIN DE0007251803) on 25 September 2014 amounts to 2.37% (this corresponds to 1,435,866 out of a total of 60,533,360 voting rights (the 'Total Voting Rights')). 1.43% of the Total Voting Rights (this corresponds to 865,475 voting rights) are to be attributed to BlackRock Financial Management, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG. 0.75% of the Total Voting Rights (this corresponds to 455,881 voting rights) are to be attributed to BlackRock Financial Management, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.05% of the Total Voting Rights (this corresponds to 30,890 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.14% of the Total Voting Rights (this corresponds to 83,620 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 2 in connection with sentence 2 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 30.09.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany Internet: www.stada.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------